Imagine your baby’s burning up with fever. You don’t know if it’s something serious or just the flu. What if instead of rushing to a doctor and conducting a sequence of cumbersome tests at a central lab, you could diagnose the ailment yourself at home within half an hour? A device with a ‘fever of unknown origin’ panel could tell if it’s malaria, dengue, typhoid or just a viral infection. If Achira Labs’ work on building a marketable, cost-efficient lab on a chip goes according to plan, that day may not be very far away.
Achira’s work on diagnostic lab-on-a-chip technology could disrupt the market
Summer wine and salad
Kishore Singh - January 19, 2015
The million-dollar question: Is investing a game of luck or skill?
Shankar Sharma - May 04, 2021
Every crisis is an opportunity, if you are on the right side of equities
Samir Arora - May 04, 2021
Viraj Mehta trusts the toughness and bounce of a company that has seen many trials
Viraj Mehta - May 04, 2021
Safir Anand spots a mid-sized company with the right chemistry and catalytic circumstances
Safir Anand - May 07, 2021